Adverse events of capecitabine in gastric cancer patients: a real‐world pharmacovigilance study based on the FAERS database
Background Capecitabine stands as a pivotal chemotherapeutic agent in gastric cancer (GC) management. While its general safety profile has been documented, comparative pharmacovigilance analyses of distinct capecitabine-based treatment regimens among GC patients remain scarce. Methods This study extracted AE reports fr...